跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
3-PO
首页
药物
3-PO
3-PO
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
O/W emulsified composition
US 8691191 B2
申请人: TAKAKURA TOMIKO
优先权: 2008
CN
EP
US
WO
5 件公开
US 2011206627 A1
申请人: SHISEIDO CO LTD
优先权: 2008
US
2 件公开
ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION
EP 3999493 B1
申请人: ABIVAX
优先权: 2019
CN
EP
US
WO
5 件公开
US 2021122732 A1
申请人: ABIVAX
优先权: 2018
CN
US
WO
4 件公开
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
US 6939886 B2
申请人: WYETH CORP
优先权: 2001
CN
US
5 件公开
Rod shaped apatite crystals having a specific length-to-width ratio
US 7153482 B2
申请人: BASF AG
优先权: 2001
CN
US
5 件公开
6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
US RE44733 E
申请人: ZHANG MINGIANG
优先权: 1999
US
4 件公开
TREATMENT OF PUBLIC SPEAKING ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST
EP 4251158 A1
申请人: VANDA PHARMACEUTICALS INC
优先权: 2020
EP
US
WO
3 件公开
1,3-dihydroxy substituted phenylamide glucokinase activators
US 8222285 B2
申请人: CHEN SEAN
优先权: 2008
CN
US
3 件公开
Preservative mixture
US 11400035 B2
申请人: SYMRISE AG
优先权: 2016
US
WO
3 件公开
Use of etodolac to treat hyperplasia
US 7211599 B2
申请人: CEPHALON INC
优先权: 2003
US
3 件公开
Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof
US 7273523 B2
申请人: KYPHON INC
优先权: 2004
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈